Article ID Journal Published Year Pages File Type
9872506 International Journal of Radiation Oncology*Biology*Physics 2005 6 Pages PDF
Abstract
Conclusions: Oxaliplatin, cisplatin, fluouracil, and radiotherapy can be administered together with acceptable toxicity. A Phase II trial is ongoing with resectable esophageal and gastric carcinoma.
Keywords
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Preview
Phase I trial of oxaliplatin in combination with cisplatin, protacted-infusion fluorouracil, and radiotherapy in advanced esophageal and gastroesophageal carcinoma
Authors
, , , , , , , , , ,